And this morning, focus on digestive cancer…that is, all malignant tumors that develop initially in the digestive tract, esophagus, stomach, small intestine, colon and glands, or liver and pancreas.
- How can this cancer be detected?
- What is the treatment?
- What are the risk factors?
- What are genetic predispositions, environmental and lifestyle factors?
- What hope does research have for eradicating these cancers, especially the most aggressive, pancreatic cancer?
Our experts are waiting for your questions and your testimony on the switchboard and on WhatsApp on 01 45 24 7000, on the France Inter app and on the GBVF Facebook page…
with
- Remy Nicole Researcher and Head of the Translational Genomics Team of Pancreatic Neoplasia Heterogeneity at the Inflammation Research Center (Unit 1149 Inserm/University Paris-CT) in Paris.
- Dr Antoine Hollebeck Villejuif, an oncologist at the Gustave Roussy Institute
- Vincentian rebors Professor, Head of the Department of Pancreatic and Digestive Oncology, Beaujon Hospital, AP-HP, Rare Pancreatic Disease Center Coordinator.
- Marie-Christine Boutron-RualFirst-class research director, internist and hepato-gastroenterologist at Insurm at the Institut Mutualist Montsouris in Paris.
+ column so here it isAdrian Chaboche
